Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Age
14–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged between 18 and 60 years
Clinically and postoperatively pathologically diagnosed with a benign facial lesion (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment
Voluntarily agree to participate in this study and sign a written informed consent form
Commit to complying with all study procedures and cooperate to complete all follow-up visits and data collection
You may not be if
Clinically or postoperatively pathologically diagnosed with a malignant facial tumor
Wounds requiring staged excision or planned for secondary intention healing
Surgical site located on or immediately adjacent to a mucosal surface
Known history of allergy to surgical gauze dressings or related materials
Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infection, etc.)
Concurrent use of medications known to affect wound healing or scar formation (e.g., long-term use of glucocorticoids, immunosuppressants, etc.)
Pregnant or lactating women
Refusal to sign the informed consent form, or are anticipated to have difficulty complying with study follow-up and data collection
Concurrent participation in another interventional clinical trial
Any other factors deemed by the investigator as likely to interfere with the study results or increase the participant's risk
Clareo Health | Optimizing the Timing for Facial Surgical Dressing Removal